Literature DB >> 11997156

A universal newborn hearing screening program in Taiwan.

Hung-Ching Lin1, Min-Tsan Shu, Ke-Chang Chang, Sharon M Bruna.   

Abstract

OBJECTIVE: Mackay Memorial Hospital and the Children's Hearing Foundation established a pilot universal newborn hearing screening program in November 1998. Our objective was to assess the feasibility, accuracy and cost effectiveness of implementing universal newborn hearing screening in Taiwan.
METHOD: Between November 1998 and October 2000 a total of 6765 newborns were screened for hearing loss prior to discharge from the wellborn nursery at Mackay Memorial Hospital. The average age of the subjects at the initial screening test was 52 h. The program employed a three stage hearing screening protocol using transient evoked otoacoustic emmisions (TEOAE) screening with referral for diagnostic auditory brainstem response assessment.
RESULTS: The mean TEOAE screening time per ear was 41.43 s. The overall pass rate at the time of hospital discharge was 93.6%. Thus achieving an acceptable referral rate of 6.4% for diagnostic audiological assessments. Nine newborns were identified with permanent bilateral hearing impairment. 26 newborns were identified with permanent unilateral hearing impairment. Infants identified with bilateral hearing loss were immediately referred to the Children's Hearing Foundation for hearing aid assessment and fitting. Infants as young as 5 weeks of age were successfully fitted with hearing instruments and enrolled in the family centered early intervention program at the Children's Hearing Foundation.
CONCLUSION: The frequency of bilateral congenital hearing loss requiring amplification in this population is shown to be approximately 1 in 752 newborns. This finding is consistent with previous research, which has indicated hearing loss to be the most frequently occurring birth defect. Universal newborn hearing screening using TEOAEs proved to be a cost effective and feasible method of identifying congenital hearing loss in Taiwan. The existence of many successful screening programs worldwide and the availability of fast, objective, reliable and inexpensive hearing screening procedures means that universal newborn hearing screening is becoming the standard of care.

Entities:  

Mesh:

Year:  2002        PMID: 11997156     DOI: 10.1016/s0165-5876(02)00011-3

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

Review 1.  Universal newborn hearing screening, a revolutionary diagnosis of deafness: real benefits and limitations.

Authors:  George X Papacharalampous; Thomas P Nikolopoulos; Dimitrios I Davilis; Ioannis E Xenellis; Stavros G Korres
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-23       Impact factor: 2.503

2.  Comparison of Two-Step Transient Evoked Otoacoustic Emissions and One-Step Automated Auditory Brainstem Response for Universal Newborn Hearing Screening Programs in Remote Areas of China.

Authors:  Haibin Sheng; Qian Zhou; Qixuan Wang; Yun Yu; Lihua Liu; Meie Liang; Xueyan Zhou; Hao Wu; Xiangrong Tang; Zhiwu Huang
Journal:  Front Pediatr       Date:  2021-05-14       Impact factor: 3.418

3.  Progress towards early detection services for infants with hearing loss in developing countries.

Authors:  Bolajoko O Olusanya; De Wet Swanepoel; Mônica J Chapchap; Salvador Castillo; Hamed Habib; Siti Z Mukari; Norberto V Martinez; Hung-Ching Lin; Bradley McPherson
Journal:  BMC Health Serv Res       Date:  2007-01-31       Impact factor: 2.655

4.  Assessment of the feasibility and coverage of a modified universal hearing screening protocol for use with newborn babies of migrant workers in Beijing.

Authors:  Beier Qi; Xiaohua Cheng; Hui En; Bo Liu; Shichun Peng; Yong Zhen; Zhenghua Cai; Lihui Huang; Luo Zhang; Demin Han
Journal:  BMC Pediatr       Date:  2013-08-08       Impact factor: 2.125

5.  Comparison of Newborn Hearing Screening in Well-Baby Nursery and NICU: A Study Applied to Reduce Referral Rate in NICU.

Authors:  Pei-Chun Li; Wei-I Chen; Chih-Ming Huang; Ching-Ju Liu; Hsiu-wen Chang; Hung-Ching Lin
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.